GAMMA Investing’s Mereo BioPharma MREO Stock Holding History

GAMMA Investing’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.96K	Sell	9,308 -9,966	-52%	-$2.99K	﹤0.01%	3657
2026 Q1	$6.36K	Buy	19,274 +9,713	+102%	+$4.17K	﹤0.01%	3276
2025 Q4	$3.98K	Buy	9,561 +380	+4%	+$723	﹤0.01%	3374
2025 Q3	$18.9K	Sell	9,181 -76	-0.8%	-$140	﹤0.01%	2542
2025 Q2	$25.1K	Buy	9,257 +877	+10%	+$2.12K	﹤0.01%	2344
2025 Q1	$18.9K	Sell	8,380 -621	-7%	-$1.76K	﹤0.01%	2415
2024 Q4	$31.5K	Sell	9,001 -1,692	-16%	-$6.65K	﹤0.01%	2012
2024 Q3	$43.9K	Buy	10,693 +3,928	+58%	+$16.3K	﹤0.01%	1585
2024 Q2	$24.4K	Buy	6,765 +778	+13%	+$2.52K	﹤0.01%	1719
2024 Q1	$19.8K	Buy	5,987 +1,375	+30%	+$4.66K	﹤0.01%	1656
2023 Q4	$17.5K	Buy	+4,612	New	+$8.82K	﹤0.01%	1594

Other funds holding MREO

SWP

Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return

GAMMA Investing's MREO Position: Q2 2026 in Review

GAMMA Investing reduced its Mereo BioPharma (MREO) stake by 52% in Q2 2026, selling an estimated $2.99K and leaving 9,308 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

GAMMA Investing first reported a position in MREO in Q4 2023 and has held it in 11 quarters since. The position peaked at $43.9K in Q3 2024. 2 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

GAMMA Investing held 9,308 shares of Mereo BioPharma worth $2.96K as of Q2 2026.
GAMMA Investing sold 9,966 Mereo BioPharma shares in Q2 2026, an estimated $2.99K.
Mereo BioPharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3657 holding.
GAMMA Investing first reported a position in Mereo BioPharma in Q4 2023 and has held it in 11 quarters since.
GAMMA Investing's Mereo BioPharma position peaked at $43.9K in Q3 2024.
2 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.